Anti-inflammatory substances based on components of human cells could one day improve treatment in patients. Researchers have developed a method for producing those substances with controlled quality. Since the body does not recognize them as foreign substances, they offer advantages over anti-inflammatory drugs such as ibuprofen or diclofenac.